All In MedTech

Device Trial Radar · NCT03125460

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer

Last checked: Nov 20, 2026Latest source record: Feb 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

424

Actual

Start

Dec 2016

Primary completion

Feb 2019

Study completion May 2019

Sponsor

Lead sponsor
CepheidNot on our public-company list
Sponsor type
Industry
First posted
Apr 24, 2017

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 40 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to establish the performance characteristics of an assay that detects the recurrence of bladder cancer in patients previously diagnosed with bladder cancer. The study is conducted at locations within and outside of the United States. Testing is performed on urine specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.

Conditions

  • Bladder Cancer

Interventions

  • Xpert Bladder Cancer MonitorDevice

    in vitro diagnostic test for the recurrence of bladder cancer in patients that have been previously diagnosed with bladder cancer

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparison to histology for positive or suspicious cystoscopyTime frame: Baseline = Subject Enrollment
  2. Comparison to histology for positive or suspicious cystoscopyTime frame: Follow up = 12 months from Subject Enrollment (Baseline)

Locations

17 sites in 3 countries. Site status is shown where the registry gives one.

  • PAVA

    Palo Alto, California

  • The Urology Center of Colorado, P.C.

    Denver, Colorado

  • Urology Associates, P.C.

    Englewood, Colorado

14 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.